Lung Cancer

1

Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: Is cardiovascular death under-reported?

Sun, F., Franks, K., Murray, L., Lilley, J., Wheller, B., Banfill, K., McWilliam, A., Abravan, A, Van Herk, M., Faivre-Finn, C., Cubbon, R.

Journal:

Lung Cancer

Year:

2020

File:

PDF, 1.78 MB

2020

2

Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer

Jung, Hyun Ae, Noh, Jae Myoung, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Pyo, Hongryull, Ahn, Yong Chan, Park, Keunchil

Journal:

Lung Cancer

Year:

2020

File:

PDF, 445 KB

2020

3

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) â A decision-making analysis amongst European lung cancer experts

FrÃ¼h, M., Panje, C.M., Reck, M., Blackhall, F., Califano, R., Cappuzzo, F., Besse, B., Novello, S., Garrido, P., Felip, E., O'Brien, M., Paz Ares, L., de Marinis, F., Westeel, V., De Ruysscher, D., P

Journal:

Lung Cancer

Year:

2020

File:

PDF, 763 KB

2020

4

A phase III, randomized, double-blind, multicenter study to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB8 (proposed bevacizumab biosimilar) and reference bevacizumab in patients with metastatic or recurrent nonsquamous non-small cell lung cancer

Reck, Martin, Luft, Alexander, Bondarenko, Igor, Shevnia, Serhii, Trukhin, Dmytro, Kovalenko, Nadezhda V., Vacharadze, Kakha, Andrea, FÃ¼lÃ¶p, Hontsa, Anatoliy, Choi, Jihye, Shin, Donghoon

Journal:

Lung Cancer

Year:

2020

File:

PDF, 1.94 MB

2020

5

Cumulative pemetrexed dose increases the risk of nephrotoxicity

de Rouw, N., Boosman, R.J., van de Bruinhorst, H., Biesma, B., van den Heuvel, M.M., Burger, D.M., Hilbrands, L.B., ter Heine, R., Derijks, H.J.

Journal:

Lung Cancer

Year:

2020

File:

PDF, 267 KB

2020

6

Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study)

Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil

Journal:

Lung Cancer

Year:

2020

File:

PDF, 2.91 MB

2020

7

The role of spread through air spaces (STAS) in lung adenocarcinoma prognosis and therapeutic decision making

Toki, Maria I., Harrington, Kevin, Syrigos, Konstantinos N.

Journal:

Lung Cancer

Year:

2020

File:

PDF, 792 KB

2020

8

Durvalumab vs placebo consolidation therapy after chemoradiotherapy in stage III non-small-cell lung cancer: An updated PACIFIC trial-based cost-effectiveness analysis

Han, Jiaqi, Tian, Kun, Yang, Jiangping, Gong, Youling

Journal:

Lung Cancer

Year:

2020

File:

PDF, 939 KB

2020

9

NEUROD1 is highly expressed in extensive-disease small cell lung cancer and promotes tumor cell migration

Ikematsu, Yuki, Tanaka, Kentaro, Toyokawa, Goji, Ijichi, Kayo, Ando, Nobuhisa, Yoneshima, Yasuto, Iwama, Eiji, Inoue, Hiroyuki, Tagawa, Tetsuzo, Nakanishi, Yoichi, Okamoto, Isamu

Journal:

Lung Cancer

Year:

2020

File:

PDF, 5.58 MB

2020

10

Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer

Sharpnack, Michael F., Cho, Ju Hwan, Johnson, Travis S., Otterson, Gregory A., Shields, Peter G., Huang, Kun, Carbone, David P., He, Kai

Journal:

Lung Cancer

Year:

2020

File:

PDF, 1.34 MB

2020

11

NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer

Leal, Jose Luis, Peters, Geoffrey, Szaumkessel, Marcin, Leong, Trishe, Asadi, Khashayar, Rivalland, Gareth, Do, Hongdo, Senko, Clare, Mitchell, Paul L., Quing, Chai Zi, Dobrovic, Alexander, Thapa, Bib

Journal:

Lung Cancer

Year:

2020

File:

PDF, 1.53 MB

2020

12

The clinical efficacy of combinatorial therapy of EGFR-TKI and crizotinib in overcoming MET amplification-mediated resistance from prior EGFR-TKI therapy

Wang, Yubo, Tian, Panwen, Xia, Lei, Li, Li, Han, Rui, Zhu, Mengxiao, Lizaso, Analyn, Qin, Tian, Li, Min, Yu, Bing, Mao, Xinru, Han-Zhang, Han, He, Yong

Journal:

Lung Cancer

Year:

2020

File:

PDF, 2.56 MB

2020

13

Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis

Lam, Andrew C.L., Aggarwal, Reenika, Cheung, Serina, Stewart, Erin L., Darling, Gail, Lam, Stephen, Xu, Wei, Liu, Geoffrey, Kavanagh, John

Journal:

Lung Cancer

Year:

2020

File:

PDF, 1.71 MB

2020

14

Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre

Chan, Gloria HJ, Gwee, Yong Xiang, Low, Jia Li, Huang, Yiqing, Chan, Zhi Yao, Choo, Joan RE, Ngoi, Natalie YL, LE Ang, Yvonne, Muthu, Vaishnavi, Chong, Wan Qin, Wong, Alvin, Soo, Ross A.

Journal:

Lung Cancer

Year:

2020

File:

PDF, 1.28 MB

2020

15

Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells

Otsuka, Kenji, Mitsuhashi, Atsushi, Goto, Hisatsugu, Hanibuchi, Masaki, Koyama, Kazuya, Ogawa, Hirohisa, Ogino, Hirokazu, Saijo, Atsuro, Kozai, Hiroyuki, Yoneda, Hiroto, Tobiume, Makoto, Kishuku, Masa

Journal:

Lung Cancer

Year:

2020

File:

PDF, 2.67 MB

2020

16

Survival and prognostic factors in elderly patients receiving second-line chemotherapy for relapsed small-cell lung cancer: Results from the Japanese Joint Committee of Lung Cancer Registry

Igawa, Satoshi, Naoki, Katsuhiko, Shintani, Yasushi, Sekine, Ikuo, Shukuya, Takehito, Takayama, Koichi, Inoue, Akira, Okamoto, Isamu, Kiura, Katsuyuki, Takahashi, Kazuhisa, Yamamoto, Nobuyuki, Takiguc

Journal:

Lung Cancer

Year:

2020

File:

PDF, 352 KB

2020

17

Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors

Zhao, Dan, Mambetsariev, Isa, Li, Haiqing, Chen, Chen, Fricke, Jeremy, Fann, Patricia, Kulkarni, Prakash, Xing, Yan, Lee, Peter P., Bild, Andrea, Massarelli, Erminia, Koczywas, Marianna, Reckamp, Kare

Journal:

Lung Cancer

Year:

2020

File:

PDF, 2.31 MB

2020

18

Phase I/II study of carboplatin plus weekly nab-paclitaxel in patients aged â¥75 years with squamous-cell lung cancer: TORG1322

Zenke, Yoshitaka, Niho, Seiji, Umemura, Shigeki, Ishihara, Masashi, Seki, Nobuhiko, Nogami, Naoyuki, Hosomi, Yukio, Shimokawa, Tsuneo, Tokito, Takaaki, Goto, Yasushi, Miura, Yosuke, Saito, Haruhiro, H

Journal:

Lung Cancer

Year:

2020

File:

PDF, 755 KB

2020

19

Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype

Fornacon-Wood, Isabella, Faivre-Finn, Corinne, OâConnor, James P.B., Price, Gareth J.

Journal:

Lung Cancer

Year:

2020

File:

PDF, 906 KB

2020

20

Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center ZÃ¼rich and the Epidemiological Cancer Registry Zurich and Zug

Stahel, R.A., Curioni-Fontecedro, A., Rohrmann, S., Dafni, U., Sandner, U., Opitz, I., Andratschke, N., Franzen, D., Dimopoulou, G., Matthes, K.L., Kohler, M., Guckenberger, M., Weder, W.

Journal:

Lung Cancer

Year:

2020

File:

PDF, 742 KB

2020

21

Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy

Chen, Chao, Wang, Wei, Yu, Zhe, Tian, Shilin, Li, Yuliang, Wang, Yongzheng

Journal:

Lung Cancer

Year:

2020

File:

PDF, 2.19 MB

2020

22

Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer

Cui, Wanyuan, Franchini, Fanny, Alexander, Marliese, Officer, Ann, Wong, Hui-Li, IJzerman, Maarten, Desai, Jayesh, Solomon, Benjamin J.

Journal:

Lung Cancer

Year:

2020

File:

PDF, 3.29 MB

2020

23

Comprehensive assessment of PD-L1 immunohistochemistry on paired tissue and cytology specimens from non-small cell lung cancer

GagnÃ©, AndrÃ©anne, Orain, MichÃ¨le, Ionescu, Diana, Tsao, Ming-Sound, Joubert, David, Joubert, Philippe

Journal:

Lung Cancer

Year:

2020

File:

PDF, 1.69 MB

2020

24

Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients

Yang, Weixiong, You, Na, Jia, Minghan, Yeung, Sai-Ching Jim, Ou, Wei, Yu, Man, Wang, Yinguang, Fu, Xiayu, Zhang, Zhanfei, Yang, Jiali, Lao, Zengding, Liu, Zhenguo, Zeng, Bo, Ou, Qiuxiang, Wu, Xue, Sha

Journal:

Lung Cancer

Year:

2020

File:

PDF, 1.64 MB

2020

25

What is the role of reirradiation in the management of locoregionally relapsed non small-cell lung cancer?

Nicosia, Luca, Di Muzio, Jacopo, Agolli, Linda, Alongi, Filippo, Mazzola, Rosario, Valeriani, Maurizio, Badellino, Serena, Osti, Mattia F., Ricardi, Umberto

Journal:

Lung Cancer

Year:

2020

File:

PDF, 313 KB

2020

26

Characteristics and outcomes of lung cancer in solid organ transplant recipients

Chen, Lanyi Nora, Spivack, John, Cao, Thu, Saqi, Anjali, Benvenuto, Luke J., Bulman, William A., Mathew, Matthen, Stoopler, Mark B., Arcasoy, Selim M., Stanifer, Bryan P., Rizvi, Naiyer A., Shu, Cathe

Journal:

Lung Cancer

Year:

2020

File:

PDF, 220 KB

2020

27

Early initiated postoperative rehabilitation enhances quality of life in patients with operable lung cancer: Secondary outcomes from a randomized trial

Sommer, Maja Schick, Vibe-Petersen, Jette, StÃ¦rkind, Maja Bohlbro, Langer, Seppo W., Larsen, Klaus Richter, Trier, Karen, Christensen, Merete, Clementsen, Paul F., Missel, Malene, Christensen, Karl B

Journal:

Lung Cancer

Year:

2020

File:

PDF, 180 KB

2020

28

Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively

Corsini, Erin M., Wang, Qi, Tran, Hai T., Mitchell, Kyle G., Antonoff, Mara B., Hofstetter, Wayne L., Mehran, Reza J., Rice, David C., Roth, Jack A., Swisher, Stephen G., Vaporciyan, Ara A., Walsh, Ga

Journal:

Lung Cancer

Year:

2020

File:

PDF, 1.81 MB

2020

29

Overcoming resistance to anti-PD-1 immunotherapy in lymphoepithelioma-like carcinoma: A case report and review of the literature

Tang, Zhengwu, Fang, Rui, Tong, Guihui, Liu, Peng, Ou, Zhuâan, Tang, Yong

Journal:

Lung Cancer

Year:

2020

File:

PDF, 1.39 MB

2020

30

In response to She et al., âCost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greaterâ

Huang, Min, Insinga, Ralph P., Burke, Thomas, Zhang, Ying, de Lima Lopes, Gilberto

Journal:

Lung Cancer

Year:

2020

File:

PDF, 438 KB

2020

31

Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes

Hurkmans, Daan P., Tamminga, Menno, van Es, Bram, Peters, Tom, Karman, Wouter, van Wijck, Rogier T.A., van der Spek, Peter J., Tauber, Tjebbe, Los, Maureen, van Schetsen, Anouk, Vu, Thu, Hiltermann, T

Journal:

Lung Cancer

Year:

2020

File:

PDF, 5.81 MB

2020

32

Editorial Board

Journal:

Lung Cancer

Year:

2020

File:

PDF, 77 KB

2020

34

Corrigendum to âStepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancerâ [Lung Cancer 142 (2020) 28â33]

Suh, Jee Won, Jeong, Yong Hyu, Cho, Arthur, Kim, Dae Joon, Chung, Kyoung Young, Shim, Hyo Sup, Lee, Chang Young

Journal:

Lung Cancer

Year:

2020

File:

PDF, 112 KB

2020

Volume 146

Cardiovascular mortality and morbidity following radical radiotherapy for lung cancer: Is cardiovascular death under-reported?

Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) â A decision-making analysis amongst European lung cancer experts

A phase III, randomized, double-blind, multicenter study to compare the efficacy, safety, pharmacokinetics, and immunogenicity between SB8 (proposed bevacizumab biosimilar) and reference bevacizumab in patients with metastatic or recurrent nonsquamous non-small cell lung cancer

Cumulative pemetrexed dose increases the risk of nephrotoxicity

Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study)

The role of spread through air spaces (STAS) in lung adenocarcinoma prognosis and therapeutic decision making

Durvalumab vs placebo consolidation therapy after chemoradiotherapy in stage III non-small-cell lung cancer: An updated PACIFIC trial-based cost-effectiveness analysis

NEUROD1 is highly expressed in extensive-disease small cell lung cancer and promotes tumor cell migration

Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer

NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer

The clinical efficacy of combinatorial therapy of EGFR-TKI and crizotinib in overcoming MET amplification-mediated resistance from prior EGFR-TKI therapy

Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis

Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre

Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells

Survival and prognostic factors in elderly patients receiving second-line chemotherapy for relapsed small-cell lung cancer: Results from the Japanese Joint Committee of Lung Cancer Registry

Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors

Phase I/II study of carboplatin plus weekly nab-paclitaxel in patients aged â¥75 years with squamous-cell lung cancer: TORG1322

Radiomics as a personalized medicine tool in lung cancer: Separating the hope from the hype

Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center ZÃ¼rich and the Epidemiological Cancer Registry Zurich and Zug

Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy

Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer

Comprehensive assessment of PD-L1 immunohistochemistry on paired tissue and cytology specimens from non-small cell lung cancer

Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients

What is the role of reirradiation in the management of locoregionally relapsed non small-cell lung cancer?

Characteristics and outcomes of lung cancer in solid organ transplant recipients

Early initiated postoperative rehabilitation enhances quality of life in patients with operable lung cancer: Secondary outcomes from a randomized trial

Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively

Overcoming resistance to anti-PD-1 immunotherapy in lymphoepithelioma-like carcinoma: A case report and review of the literature

In response to She et al., âCost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greaterâ

Molecular data show conserved DNA locations distinguishing lung cancer subtypes and regulation of immune genes

Contents

Editorial Board

Corrigendum to âStepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancerâ [Lung Cancer 142 (2020) 28â33]